Related references
Note: Only part of the references are listed.Anticancer Chemotherapy Inhibits MHC Class I-Related Chain A Ectodomain Shedding by Downregulating ADAM10 Expression in Hepatocellular Carcinoma
Keisuke Kohga et al.
CANCER RESEARCH (2009)
Molecularly targeted therapy for hepatocellular carcinoma
Shinji Tanaka et al.
CANCER SCIENCE (2009)
How lipid flippases can modulate membrane structure
Philippe F. Devaux et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2008)
Tumor-associated MICA is shed by ADAM proteases
Inja Waldhauer et al.
CANCER RESEARCH (2008)
Serum levels of soluble major histocompatibility complex (MHC) class I-related chain A in patients with chronic liver diseases and changes during transcatheter arterial embolization for hepatocellular carcinoma
Keisuke Kohga et al.
CANCER SCIENCE (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
ADAMs in cancer cell proliferation and progression
Satsuki Mochizuki et al.
CANCER SCIENCE (2007)
Intrahepatic delivery of alpha-galactosylceramide-pulsed dendritic cells suppresses liver tumor
Tomohide Tatsumi et al.
HEPATOLOGY (2007)
Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5
Li Liu et al.
CANCER RESEARCH (2006)
The role of the NKG2D receptor for tumor immunity
Jerome D. Coudert et al.
SEMINARS IN CANCER BIOLOGY (2006)
Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients
Kenichi Takayasu et al.
GASTROENTEROLOGY (2006)
Soluble MICA in malignant diseases
S Holdenrieder et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas
M Jinushi et al.
JOURNAL OF HEPATOLOGY (2005)
NKG2D in NK and T cell-mediated immunity
K Ogasawara et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2005)
NK cell compartments and their activation by dendritic cells
G Ferlazzo et al.
JOURNAL OF IMMUNOLOGY (2004)
Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma
L Raffaghello et al.
NEOPLASIA (2004)
Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer
JD Wu et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Primary liver cancer:: Worldwide incidence and trends
FX Bosch et al.
GASTROENTEROLOGY (2004)
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
G Fattovich et al.
GASTROENTEROLOGY (2004)
Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia
HR Salih et al.
BLOOD (2003)
CD1d-mediated stimulation of natural killer T cells selectively activates hepatic natural killer cells to eliminate experimentally disseminated hepatoma cells in murine liver
T Miyagi et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid
M Jinushi et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
V Groh et al.
NATURE (2002)
Cutting edge: Down-regulation of MICA on human tumors by proteolytic shedding
HR Salih et al.
JOURNAL OF IMMUNOLOGY (2002)
A basolateral sorting motif in the MICA cytoplasmic tail
H Suemizu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Immunology of the healthy liver: Old questions and new insights
WZ Mehal et al.
GASTROENTEROLOGY (2001)
Innate and adaptive lymphoid cells in the human liver
DG Doherty et al.
IMMUNOLOGICAL REVIEWS (2000)
Share Paper
